Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma
Soudeh Ghafouri‐Fard, Mahdi Gholipour, Bashdar Mahmud Hussen, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Epigenetics in hepatocellular carcinoma
Ganji Purnachandra Nagaraju, Begum Dariya, Prameswari Kasa, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 622-632
Closed Access | Times Cited: 194
Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications
Khalid Otmani, Philippe Lewalle
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 159
The regulatory mechanisms of oncomiRs in cancer
Khalid Otmani, Rédouane Rouas, Mimoune Berehab, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116165-116165
Open Access | Times Cited: 10
Combinatorial Gene Expression Profiling of Serum HULC, HOTAIR, and UCA1 lncRNAs to Differentiate Hepatocellular Carcinoma from Liver Diseases: A Systematic Review and Meta-Analysis
Lalita Lumkul, Phatcharida Jantaree, Kritsada Jaisamak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1258-1258
Open Access | Times Cited: 6
Nucleus‐specific RNAi nanoplatform for targeted regulation of nuclear lncRNA function and effective cancer therapy
Zixian Huang, Shaomin Liu, Nan Lü, et al.
Exploration (2022) Vol. 2, Iss. 5
Open Access | Times Cited: 25
Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma
Wei Wei, Chao Liu, Meng Wang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 22
A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma—From m6A Modification to Blood Biomarkers
Jung Woo Eun, Jae Youn Cheong, Jee‐Yeong Jeong, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2272-2272
Open Access | Times Cited: 11
Novel biomarkers for monitoring and management of hepatocellular carcinoma
Roya Solhi, Mahsa Pourhamzeh, Ali Zarrabi, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Epigenetic Changes Affecting the Development of Hepatocellular Carcinoma
Ewa Wolińska, Maciej Skrzypczak
Cancers (2021) Vol. 13, Iss. 16, pp. 4237-4237
Open Access | Times Cited: 21
The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC
Ioana Rusu, Radu Pîrlog, Paul Chiroi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12370-12370
Open Access | Times Cited: 16
The Role of Macroautophagy and Chaperone-Mediated Autophagy in the Pathogenesis and Management of Hepatocellular Carcinoma
Anastasia Karampa, Anna Goussia, Georgios K. Glantzounis, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 760-760
Open Access | Times Cited: 15
Regulation of the Key Epithelial Cancer Suppressor miR-124 Function by Competing Endogenous RNAs
Э. А. Брага, М. В. Фридман, A. M. Burdennyy, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13620-13620
Open Access | Times Cited: 15
Circular RNA ZNF609 drives tumor progression by regulating the miR-138-5p/SIRT7 axis in melanoma
Quan Liu, Wei Cui, Chao Yang, et al.
Aging (2021) Vol. 13, Iss. 15, pp. 19822-19834
Open Access | Times Cited: 16
Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression
Feiran Wang, Lirong Zhu, Qiang Xue, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 10
Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma
Wenjie Zhang, Wenlong Wu, Qiang Meng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC
Danira Ashraf Habashy, Merna Hatem Mohamed Hamad, Manon Ragheb, et al.
Life Sciences (2022) Vol. 310, pp. 121075-121075
Closed Access | Times Cited: 10
LncRNA TP53TG1 Promotes the Growth and Migration of Hepatocellular Carcinoma Cells via Activation of ERK Signaling
Qingchun Lu, Qian Guo, Mingyang Xin, et al.
Non-Coding RNA (2021) Vol. 7, Iss. 3, pp. 52-52
Open Access | Times Cited: 13
Novel Insights into MEG3/miR664a-3p/ADH4 Axis and Its Possible Role in Hepatocellular Carcinoma from an in Silico Perspective
Shreyas H. Karunakara, Lakshana D. Puttahanumantharayappa, Nirmala G. Sannappa Gowda, et al.
Genes (2022) Vol. 13, Iss. 12, pp. 2254-2254
Open Access | Times Cited: 8
Exploring the Regulatory Role of XIST-microRNAs/mRNA Network in Circulating CD4+ T Cells of Hepatocellular Carcinoma Patients
Lien‐Hung Huang, Cheng‐Shyuan Rau, Yueh‐Wei Liu, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1848-1848
Open Access | Times Cited: 4
Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma
Mete Ucdal
Hepatology forum/Hepatology forum (Online) (2024), pp. 150-160
Open Access | Times Cited: 1
PBMC CDC42 reveals the disease activity and treatment efficacy of TNF inhibitor in patients with ankylosing spondylitis
Qian Zhang, Du Jin, Xiaoyue Mou, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 3
Open Access | Times Cited: 6
Contribution of CRNDE lncRNA in the development of cancer and the underlying mechanisms
Soudeh Ghafouri‐Fard, Arash Safarzadeh, Bashdar Mahmud Hussen, et al.
Pathology - Research and Practice (2023) Vol. 244, pp. 154387-154387
Closed Access | Times Cited: 3
KB-68A7.1 Inhibits Hepatocellular Carcinoma Development Through Binding to NSD1 and Suppressing Wnt/β-Catenin Signalling
Shuhua Zhang, Jianqun Xu, Huấn Cao, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 5
Dysregulation of circulating CDC42 and its correlation with demographic characteristics, comorbidities, tumor features, chemotherapeutic regimen and survival profile in non‐small‐cell lung cancer patients
Jie Yan, Daihong Wan
Journal of Clinical Laboratory Analysis (2021) Vol. 36, Iss. 2
Open Access | Times Cited: 7
Long non-coding RNA X-inactive specific transcript suppresses the progression of hepatocellular carcinoma through microRNA-221-3p-targeted regulation of O6-methylguanine-DNA methyltransferase
Zushun Chen, Lu‐Nan Qi, Hongyuan Fu, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 14013-14027
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top